SNUT1_MOUSE
ID SNUT1_MOUSE Reviewed; 806 AA.
AC Q9Z315; Q8K155; Q9R1I9; Q9R270;
DT 07-FEB-2006, integrated into UniProtKB/Swiss-Prot.
DT 01-MAY-1999, sequence version 1.
DT 03-AUG-2022, entry version 133.
DE RecName: Full=U4/U6.U5 tri-snRNP-associated protein 1;
DE AltName: Full=Hypoxia-associated factor;
DE AltName: Full=Squamous cell carcinoma antigen recognized by T-cells 1;
DE Short=SART-1;
DE Short=mSART-1;
GN Name=Sart1; Synonyms=Haf;
OS Mus musculus (Mouse).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC Murinae; Mus; Mus.
OX NCBI_TaxID=10090;
RN [1]
RP NUCLEOTIDE SEQUENCE [MRNA].
RC TISSUE=Brain;
RX PubMed=9765622; DOI=10.1111/j.1349-7006.1998.tb00639.x;
RA Gotoh M., Shichijo S., Hoshino T., Imai Y., Imaizumi T., Inoue Y.,
RA Takasu H., Yamaoka T., Itoh K.;
RT "Sequence analysis of genes encoding rodent homologues of the human tumor-
RT rejection antigen SART-1.";
RL Jpn. J. Cancer Res. 89:849-854(1998).
RN [2]
RP NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, DEVELOPMENTAL STAGE, AND
RP FUNCTION.
RX PubMed=10887110;
RA Gupta M., Mungai P.T., Goldwasser E.;
RT "A new transacting factor that modulates hypoxia-induced expression of the
RT erythropoietin gene.";
RL Blood 96:491-497(2000).
RN [3]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC STRAIN=FVB/N; TISSUE=Liver;
RX PubMed=15489334; DOI=10.1101/gr.2596504;
RG The MGC Project Team;
RT "The status, quality, and expansion of the NIH full-length cDNA project:
RT the Mammalian Gene Collection (MGC).";
RL Genome Res. 14:2121-2127(2004).
RN [4]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 635-742.
RC STRAIN=C57BL/6J;
RX PubMed=11410364; DOI=10.1016/s0378-1119(01)00504-2;
RA Bolland D.J., Hewitt J.E.;
RT "Intron loss in the SART1 genes of Fugu rubripes and Tetraodon
RT nigroviridis.";
RL Gene 271:43-49(2001).
RN [5]
RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-189 AND SER-480, AND
RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC TISSUE=Brain, Kidney, Lung, Pancreas, Spleen, and Testis;
RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL Cell 143:1174-1189(2010).
CC -!- FUNCTION: Plays a role in mRNA splicing as a component of the U4/U6-U5
CC tri-snRNP, one of the building blocks of the spliceosome. May also bind
CC to DNA. Appears to play a role in hypoxia-induced regulation of EPO
CC gene expression. {ECO:0000269|PubMed:10887110}.
CC -!- SUBUNIT: Identified in the spliceosome C complex. Component of the
CC U4/U6-U5 tri-snRNP complex composed of the U4, U6 and U5 snRNAs and at
CC least PRPF3, PRPF4, PRPF6, PRPF8, PRPF31, SNRNP200, TXNL4A, SNRNP40,
CC DDX23, CD2BP2, PPIH, SNU13, EFTUD2, SART1 and USP39 (By similarity).
CC {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC -!- TISSUE SPECIFICITY: Ubiquitously expressed. Shows a high expression in
CC fetal liver and a low expression in adult liver.
CC {ECO:0000269|PubMed:10887110}.
CC -!- DEVELOPMENTAL STAGE: Expressed at maximal level at 12 dpc. Declines
CC progressively until birth. {ECO:0000269|PubMed:10887110}.
CC -!- PTM: Sumoylated with SUMO2. {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the SNU66/SART1 family. {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AB014721; BAA36583.1; -; mRNA.
DR EMBL; AF129931; AAD20645.1; -; mRNA.
DR EMBL; BC028823; AAH28823.1; -; mRNA.
DR EMBL; BC051394; AAH51394.1; -; mRNA.
DR EMBL; AF105334; AAD38450.1; -; Genomic_DNA.
DR CCDS; CCDS29460.1; -.
DR RefSeq; NP_058578.3; NM_016882.3.
DR AlphaFoldDB; Q9Z315; -.
DR SMR; Q9Z315; -.
DR BioGRID; 203075; 26.
DR IntAct; Q9Z315; 25.
DR MINT; Q9Z315; -.
DR STRING; 10090.ENSMUSP00000047397; -.
DR iPTMnet; Q9Z315; -.
DR PhosphoSitePlus; Q9Z315; -.
DR EPD; Q9Z315; -.
DR jPOST; Q9Z315; -.
DR MaxQB; Q9Z315; -.
DR PaxDb; Q9Z315; -.
DR PeptideAtlas; Q9Z315; -.
DR PRIDE; Q9Z315; -.
DR ProteomicsDB; 261465; -.
DR Antibodypedia; 30019; 219 antibodies from 36 providers.
DR DNASU; 20227; -.
DR Ensembl; ENSMUST00000044207; ENSMUSP00000047397; ENSMUSG00000039148.
DR GeneID; 20227; -.
DR KEGG; mmu:20227; -.
DR UCSC; uc008gcu.1; mouse.
DR CTD; 9092; -.
DR MGI; MGI:1309453; Sart1.
DR VEuPathDB; HostDB:ENSMUSG00000039148; -.
DR eggNOG; KOG2217; Eukaryota.
DR GeneTree; ENSGT00390000007071; -.
DR HOGENOM; CLU_009379_3_0_1; -.
DR InParanoid; Q9Z315; -.
DR OMA; EYARWEN; -.
DR OrthoDB; 1068640at2759; -.
DR PhylomeDB; Q9Z315; -.
DR TreeFam; TF318828; -.
DR Reactome; R-MMU-72163; mRNA Splicing - Major Pathway.
DR BioGRID-ORCS; 20227; 15 hits in 75 CRISPR screens.
DR ChiTaRS; Sart1; mouse.
DR PRO; PR:Q9Z315; -.
DR Proteomes; UP000000589; Chromosome 19.
DR RNAct; Q9Z315; protein.
DR Bgee; ENSMUSG00000039148; Expressed in retinal neural layer and 276 other tissues.
DR ExpressionAtlas; Q9Z315; baseline and differential.
DR Genevisible; Q9Z315; MM.
DR GO; GO:0015030; C:Cajal body; ISO:MGI.
DR GO; GO:0071013; C:catalytic step 2 spliceosome; ISO:MGI.
DR GO; GO:0005794; C:Golgi apparatus; ISO:MGI.
DR GO; GO:0016607; C:nuclear speck; ISO:MGI.
DR GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR GO; GO:0005634; C:nucleus; ISO:MGI.
DR GO; GO:0071005; C:U2-type precatalytic spliceosome; ISO:MGI.
DR GO; GO:0046540; C:U4/U6 x U5 tri-snRNP complex; ISO:MGI.
DR GO; GO:0000481; P:maturation of 5S rRNA; IBA:GO_Central.
DR GO; GO:0045292; P:mRNA cis splicing, via spliceosome; IBA:GO_Central.
DR GO; GO:0000398; P:mRNA splicing, via spliceosome; ISO:MGI.
DR GO; GO:0045585; P:positive regulation of cytotoxic T cell differentiation; ISO:MGI.
DR InterPro; IPR045347; HIND.
DR InterPro; IPR005011; SNU66/SART1.
DR PANTHER; PTHR14152; PTHR14152; 1.
DR Pfam; PF19252; HIND; 1.
DR Pfam; PF03343; SART-1; 1.
PE 1: Evidence at protein level;
KW Coiled coil; Isopeptide bond; mRNA processing; mRNA splicing; Nucleus;
KW Phosphoprotein; Reference proteome; Spliceosome; Ubl conjugation.
FT CHAIN 1..806
FT /note="U4/U6.U5 tri-snRNP-associated protein 1"
FT /id="PRO_0000223309"
FT REGION 1..121
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 418..504
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT REGION 578..610
FT /note="Disordered"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COILED 157..231
FT /evidence="ECO:0000255"
FT COILED 494..540
FT /evidence="ECO:0000255"
FT COMPBIAS 44..104
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 435..451
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT COMPBIAS 582..602
FT /note="Basic and acidic residues"
FT /evidence="ECO:0000256|SAM:MobiDB-lite"
FT MOD_RES 189
FT /note="Phosphothreonine"
FT /evidence="ECO:0007744|PubMed:21183079"
FT MOD_RES 321
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT MOD_RES 348
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT MOD_RES 430
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT MOD_RES 480
FT /note="Phosphoserine"
FT /evidence="ECO:0007744|PubMed:21183079"
FT MOD_RES 492
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT MOD_RES 527
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT MOD_RES 597
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT MOD_RES 602
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT MOD_RES 604
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT MOD_RES 627
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT MOD_RES 701
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT MOD_RES 767
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT MOD_RES 770
FT /note="Phosphothreonine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT MOD_RES 795
FT /note="Phosphoserine"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 125
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 133
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 141
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO1); alternate"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 141
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2); alternate"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 147
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 188
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 277
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 329
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 336
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 400
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 414
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 554
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 654
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 663
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 690
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 705
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 715
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 729
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 755
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 764
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 781
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 786
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CROSSLNK 797
FT /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT G-Cter in SUMO2)"
FT /evidence="ECO:0000250|UniProtKB:O43290"
FT CONFLICT 70
FT /note="A -> T (in Ref. 2; AAD20645 and 3; AAH28823/
FT AAH51394)"
FT /evidence="ECO:0000305"
FT CONFLICT 566
FT /note="C -> Y (in Ref. 2; AAD20645)"
FT /evidence="ECO:0000305"
SQ SEQUENCE 806 AA; 90885 MW; 1417E85C71BF380C CRC64;
MGSSKKHRGE KEAAGTTAAA GTGGTTEQPP RHREHKKHKH RSSGGGSSGG ERRKRSRERG
SERGSGRRGA EAEARSGAHG RERSQAEPSE RRVKREKRDD GYEAAASSKA SSGDASSLSI
EETNKLRAKL GLKPLEVNAV KKEAGTKEEP VAADVINPMA LRQREELREK LAAAKEKRLL
NQKLGKIKTL GEDDPWLDDT AAWIERSRQL QKEKDLAEKR AKLLEEMDQE FGVSTLVEEE
FEQRRQDLYS ARDLQGLTVE HAIDSFREGE TVVLTLKDKG VLQDGEDVLV NVNMVDKERA
DKNVELRKKK PDYLPYAEDE SVDDLAQQKP RSILAKYDEE LEGERPHSFR LEQGGMADGL
RERELEEIRT KLRLQAQSLS SVGPRLASEY LSPEEMVTFK KTKRRVKKIR KKEKEVIMRA
DDLLPLGDQT QDGDFGSRLR GRGRRRVPEV EEEALEDEEK DPVAQPPPSD DTRVENMDIS
DEEDGGALPP GSPEGLEEDE AELELQKQLE KGRRLRQLQQ LQQLRDSGEK VLEIVKKLES
RQRGWEEEED PERKGTIVFN ATSEFCRTLG EIPTYGLAGN REEQEELMDF ERDEERSANG
GSESDGEENI GWSTVNLDEE KQHQDFSASS TTILDEEPIV NRGLAAALLL CQNKGLLETT
VQKVARVKAP NKSLPSAVYC IEDKMAIDDK YSRREEYRGF TQDFKEKDGY KPDVKIEYVD
ETGRKLTPKE AFRQLSHRFH GKGSGKMKTE RRMKKLDEEA LLKKMSSSDT PLGTVALLQE
KQKAQKTPYI VLSGSGKSMN ANTITK
